It is estimated that as many as 10 million people, are living with PI worldwide. Over the past decade, the information and detection of Primary Immunodeficiency has greatly expanded, and knowledge of causative genes continues to rapidly grow.
In this context, JMF established the Translational Research Program to expand upon the knowledge and understanding of Primary Immunodeficiency; how to identify, diagnose and treat.
Translational Research grants are awarded to physicians and scientists who are prominent in their field with vast expertise in PI, from countries all over the world.